Model Organisms in Drug Discovery

116 DROSOPHILA AS A TOOL FOR DRUG DISCOVERY
Shilo, B. Z. (1992). Roles of receptor tyrosine kinases in Drosophila development. FASEB
J. 6, 2915–2922.
Siegal, M. L. and Hartl, D. L. (1996). Transgene coplacement and high efficiency sitespecific
recombination with the Cre/loxP system in Drosophila. Genetics 144, 715–726.
Smith, H. K., Roberts, I. J. H., Allen, M. J., Connolly, J. B., Moffat, K. G. and O’Kane,
C. J. (1996). Inducible ternary control of transgene expression and cell ablation in
Drosophila. Dev. Genes Evol. 206, 14–24.
Smith, L., Price-Jones, M., Hughes, K., Egebjerg, J., Poulsen, F., Wiberg, F. C. and Shank,
R. P. (2000). Effects of topiramate on kainate- and domoate-activated [ l4 C]guanidinium
ion flux through GluR6 channels in transfected BHK cells using Cytostar-T scintillating
microplates. Epilepsia 41, 48–51.
Snyder, R. D. and Green, J. W. (2001). A review of the genotoxicity of marketed
pharmaceuticals. Mutat. Res. 488, 151–169.
Stapleton, M., Liao, G., Brokstein, P., Hong, L., Carninci, P., Shiraki, T., Hayashizaki, Y.,
et al. (2002). The Drosophila gene collection: identification of putative full-length cDNAs
for 70% of D. melanogaster genes. Genome Res. 12, 1294–1300.
Stebbins, M. J. and Yin, J. C. (2001). Adaptable doxycycline-regulated gene expression
systems for Drosophila. Gene 270, 103–111.
Stebbins, M. J., Urlinger, S., Byrne, G., Bello, B., Hillen, W. and Yin, J. C. (2001).
Tetracycline-inducible systems for Drosophila. Proc. Natl. Acad. Sci. USA 98, 10775–
10788.
Steffan, J. S., Bodai, L., Pallos, J., Poelman, M., McCampbell, A., Apostol, B. L.,
Kazantsev, A., et al. (2001). Histone deacetylase inhibitors arrest polyglutaminedependent
neurodegeneration in Drosophila. Nature 413, 739–743.
Stocker, H. and Hafen, E. (2000). Genetic control of cell size. Curr. Opin. Genet. Dev. 10,
529–535.
Stockwell, B. R. (2000). Chemical genetics: ligand-based discovery of gene function. Nat.
Rev Genet. 1, 116–125.
Stowers, R. S. and Schwarz, T. L. (1999). A genetic method for generating Drosophila eyes
composed exclusively of mitotic clones of a single genotype. Genetics 152, 1631–1639.
Struhl, G., Fitzgerald, K. and Greenwald, I. (1993). Intrinsic activity of the Lin-12 and
Notch intracellular domains in vivo. Cell 74, 331–345.
Sullivan, W., Ashburner, M. and Hawley, R. S. (2000). Drosophila Protocols. Cold Spring
Harbor, New York: Cold Spring Harbor Laboratory Press.
Takagi, S., Kimura, M. and Katsuki, M. (1992). A rapid and efficient protocol of the
inverted PCR using two primer pairs. Biotechniques 13, 176–178.
Thale, Z., Kinder, F. R., Bair, K. W., Bontempo, J., Czuchta, A. M., Versace, R. W.,
Phillips, P. E., et al. (2001). Bengamides revisited: new structures and antitumor studies.
J. Org. Chem. 66, 1733–1741.
Theodosiou, N. A. and Xu, T. (1998). Use of FLP/FRT system to study Drosophila
development. Methods 14, 355–365.
Thibault, S. T. (2002). The piggyBac transposon complements P as a tool for large scale
forward mutagenesis. Dros. Res. Conf. Proc. 43, 969C.
Uckun, F. M. (2001). Rationally designed anti-mitotic agents with pro-apoptotic activity.
Curr. Pharm. Res. 7, 1627–1639.
Vaugeois, J. M., Corera, A. T., Deslandes, A. and Costentin, J. (1999). Although
chemically related to amineptine, the antidepressant tianeptine is not a dopamine uptake
inhibitor. Pharmacol. Biochem. Behav. 63, 285–290.
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith,
H. O., et al. (2001). The sequence of the human genome. Science 291, 1304–1351.